Works in Cancer Chemotherapy & Pharmacology, 2023, Vol 92, Issue 1

Results: 8

Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 15, doi. 10.1007/s00280-023-04544-5

By:

Rasco, Drew W.;
Medina, Theresa;
Corrie, Pippa;
Pavlick, Anna C.;
Middleton, Mark R.;
Lorigan, Paul;
Hebert, Chris;
Plummer, Ruth;
Larkin, James;
Agarwala, Sanjiv S.;
Daud, Adil I.;
Qiu, Jiaheng;
Bozon, Viviana;
Kneissl, Michelle;
Barry, Elly;
Olszanski, Anthony J.

Publication type:

Article

ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 39, doi. 10.1007/s00280-023-04539-2

By:

Kagan, Amanda B.;
Moses, Blake S.;
Lapidus, Rena;
Mott, Bryan T.;
Rai, Ganesha;
Anders, Nicole M.;
Hoag, Stephen W.;
Rudek, Michelle A.;
Civin, Curt I.

Publication type:

Article

A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 57, doi. 10.1007/s00280-023-04548-1

By:

König, Philipp;
Zhulenko, Roman;
Suparman, Eloy;
Hoffmeister, Henrik;
Bückreiß, Nico;
Ott, Ingo;
Bendas, Gerd

Publication type:

Article

Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 51, doi. 10.1007/s00280-023-04546-3

By:

Singh, Minu;
Bhaskar, Divya;
Bhatia, Prateek;
Thakur, Rozy;
Sharma, Pankaj;
Bansal, Deepak;
Jain, Richa;
Trehan, Amita

Publication type:

Article

Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 7, doi. 10.1007/s00280-023-04542-7

By:

Oura, Mitsuaki;
Oguro, Fumiya;
Agatsuma, Nobukazu;
Imamaki, Hirotaka;
Nishikawa, Yoshitaka

Publication type:

Article

Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 1, doi. 10.1007/s00280-023-04540-9

By:

Purvis, Katelyn N.;
Swanson, Hope D.;
Niloy, Kumar Kulldeep;
Zhou, Yiwang;
Panetta, John C.;
Crews, Kristine R.;
Flerlage, Jamie E.

Publication type:

Article

Subsequent treatment for locally advanced non-small-cell lung cancer that progressed after definitive chemoradiotherapy and consolidation therapy with durvalumab: a multicenter retrospective analysis (TOPGAN 2021-02).

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 29, doi. 10.1007/s00280-023-04547-2

By:

Hasegawa, Tsukasa;
Ariyasu, Ryo;
Tanaka, Hisashi;
Saito, Ryota;
Kawashima, Yosuke;
Horiike, Atsushi;
Sakatani, Toshio;
Tozuka, Takehiro;
Shiihara, Jun;
Saiki, Masafumi;
Tambo, Yuichi;
Sonoda, Tomoaki;
Miyazaki, Akito;
Uematsu, Shinya;
Tsuchiya-Kawano, Yuko;
Yanagitani, Noriko;
Nishino, Makoto

Publication type:

Article

Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 71, doi. 10.1007/s00280-023-04533-8

By:

Hong, Lan;
Wang, Xiuzhen;
Zheng, Lang;
Wang, Shengtan;
Zhu, Genhai

Publication type:

Article